Mural Oncology plc (MURA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -18.48M | -31.36M | -36.8M | -31.77M | -30.08M | -29.36M | -37.34M | -42.73M | -50.47M | -45.32M | -37.89M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 38.56% | -6.83% | 1.45% | 25.64% | 40.41% | 35.21% | - | -12.77% | - | - | - |
| Net Income | -3.71M | -47.98M | -33.14M | -34.27M | -31.76M | -31.56M | -30.92M | -59.54M | -51.28M | -50.16M | -48.58M |
| Depreciation & Amortization | 800K | 1.14M | 851K | 868K | 899K | 899K | 846K | 613K | 779K | 645K | 497K |
| Stock-Based Compensation | 0 | -1.12M | 513K | 662K | 1.03M | 1.19M | 2.2M | 15.23M | 2.98M | 3.14M | 3.2M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.46M | 0 | 0 | -4.19M |
| Other Non-Cash Items | 377K | 5.52M | -96K | 383K | -592K | -2.37M | 0 | 16.46M | 0 | 0 | 4.19M |
| Working Capital Changes | -15.95M | 11.08M | -4.93M | 591K | 344K | 2.48M | -9.47M | 966K | -2.95M | 1.06M | 7M |
| Change in Receivables | 0 | 55K | -4K | 1.34M | -388K | 890K | 3.65M | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 1.77M | 27.99M | 36.21M | 19.31M | 43.68M | -124.54M | -1.18M | -1.17M | -710K | -143K |
| Capital Expenditures | 0 | -5K | -10K | -23K | -14K | 0 | -55K | -1.18M | -1.17M | -710K | -143K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 780K | 0 | 67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 28K | 0 | 196K | 0 | 0 | 315.01M | 51.64M | 46.03M | 38.03M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 28K | 0 | 196K | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 315.01M | 51.64M | 46.03M | 38.03M |
| Net Change in Cash | -18.48M | -29.59M | -8.78M | 4.44M | -10.57M | 14.32M | -163.59M | 271.11M | 0 | 0 | 0 |
| Free Cash Flow | -18.48M | -31.37M | -36.81M | -31.79M | -30.09M | -29.36M | -37.39M | -43.9M | -51.64M | -46.03M | -38.03M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 38.59% | -6.84% | 1.56% | 27.58% | 41.72% | 36.21% | - | -15.45% | - | - | - |
| FCF per Share | -1.07 | -1.82 | -2.14 | -1.86 | -1.77 | -1.73 | -2.23 | -2.63 | -3.09 | -2.76 | -2.28 |
| FCF Conversion (FCF/Net Income) | 4.99x | 0.65x | 1.11x | 0.93x | 0.95x | 0.93x | 1.21x | 0.72x | 0.98x | 0.90x | 0.64x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |